Claire Gelfman, Ph.D.
Claire M. Gelfman, Ph.D. serves as Adverum’s vice president, pharmaceutical development. Previously, she was the senior director of scientific services at Ora, Inc., an ophthalmic contract research organization (CRO) where she designed and implemented preclinical translational strategies and integrated them into the clinical development process. Prior positions included director of ophthalmology research at Lpath Inc evaluating humanized monoclonal antibodies directed against bioactive lipids, as well as principal scientist at Lexicon Pharmaceuticals where she directed early drug discovery efforts using gene therapy, cellular, and biochemical approaches, and focused on in vivo pharmacology studies in the areas of ocular inflammation and retinal degeneration. Her experience covers more than 15 years in drug discovery and development, spanning biopharma and the CRO industry. Dr. Gelfman holds a B.A. in Biology from Washington University in St. Louis, and a Ph.D. in Biochemistry from The University of Texas at Austin.